[Updated 9/2/15 8:54 am. See below.] In 2013, Cellular Dynamics vowed to create induced pluripotent stem (iPS) cell lines from the cells of 3,000 donors—some healthy, some diseased—as part of a $32 million initiative funded by the California Institute... Read more »
Looking to take some of the fees out of sending money overseas, TransferWise is firing up its New York team for its U.S. expansion.
The London-based company says it is a lower-cost option—compared with banks and other incumbent money transfer businesses—that... Read more »
Former Genzyme CEO Henri Termeer has been active as an advisor and investor in the Boston biotech scene the past few years, forming ties with companies like Moderna Therapeutics, Lysosomal Therapeutics, Aura Biosciences, and others. The latest startup to... Read more »
Addressing the needs of a climate-changing world seems like an important cause, but many cleantech startups that are developing sustainable products face an intractable challenge.
Producing a “green” alternative for an industry already using petroleum-based raw materials usually requires selling a... Read more »
For certain parts of the population, “summer” is a verb, and in the U.S., one does it until Labor Day. One more week, then, before sunburned financial types return to their desks and biotech IPO hopefuls hit the road to plead... Read more »
As top scientists head toward a summit later this year to hammer out rules governing the use of gene editing, companies developing one form of the technology, known as CRISPR-Cas9, for human medicine continue to raise cash hand over fist.
The... Read more »
“We’re not here for the weather, obviously, but for the community.”
That was Andrew Foxwell speaking at last week’s Forward Festival in Madison, WI, about why the Wisconsin native and his wife, Gracie—after stints in Washington, DC, Chicago, and driving 30,000... Read more »
Innovation to help first responders stay safe and do their jobs better is the focus of the Emerge accelerator, which spent three months working out of Tech Wildcatters in Dallas this summer.
The program, which recently held its demo day, featured... Read more »
New drugs for fibrosis, an internal, often deadly type of scarring, have become the centerpiece of a number of biotech deals over the past few years. The latest just crossed the wires this morning, as Bristol-Myers Squibb has just nabbed an... Read more »